atai Life Sciences (ATAI) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $430.3M

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c